Literature DB >> 15935685

Neuronal damage after moderate hypoxia and erythropoietin.

Astrid Weber1, Mark Dzietko, Monika Berns, Ursula Felderhoff-Mueser, Uwe Heinemann, Rolf F Maier, Michael Obladen, Chrissanthi Ikonomidou, Christoph Bührer.   

Abstract

Both mild hypoxia and exogenous erythropoietin may protect the brain against subsequent severe hypoxia, and the conditioning effect of transient hypoxia is partly mediated by hypoxia-induced endogenous erythropoietin. We now observed in several experimental models that combining transient hypoxia and exogenous erythropoietin may cause neuronal damage. High-dose erythropoietin (40 IU/ml) profoundly impeded synaptic transmission of rat hippocampal slice cultures when used in conjunction with moderate hypoxia (10% O2 for two 8-h periods). Addition of erythropoietin increased viability of cultured rat embryonic cortical neurons at 21% O2 but decreased viability under hypoxic conditions (2% O2) in a dose-dependent fashion. Death of human neuronal precursor cells challenged by oxygen and glucose deprivation was increased by erythropoietin when cells were cultured under hypoxic but not under normoxic conditions. In neonatal rats exposed to moderate hypoxia plus erythropoietin, numbers of degenerating cerebral neurons were increased, as compared to controls or rats subjected to either hypoxia or erythropoietin alone. Thus, erythropoietin may aggravate rather than ameliorate neuronal damage when administered during transient hypoxia.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15935685     DOI: 10.1016/j.nbd.2005.04.016

Source DB:  PubMed          Journal:  Neurobiol Dis        ISSN: 0969-9961            Impact factor:   5.996


  14 in total

Review 1.  Neurotoxic saboteurs: straws that break the hippo's (hippocampus) back drive cognitive impairment and Alzheimer's Disease.

Authors:  Mak Adam Daulatzai
Journal:  Neurotox Res       Date:  2013-07-03       Impact factor: 3.911

2.  Modulation of cellular stress response via the erythropoietin/CD131 heteroreceptor complex in mouse mesenchymal-derived cells.

Authors:  Stefan Bohr; Suraj J Patel; Radovan Vasko; Keyue Shen; Arvin Iracheta-Vellve; Jungwoo Lee; Shyam Sundhar Bale; Nilay Chakraborty; Michael Brines; Anthony Cerami; Francois Berthiaume; Martin L Yarmush
Journal:  J Mol Med (Berl)       Date:  2014-11-06       Impact factor: 4.599

Review 3.  Epo and other hematopoietic factors.

Authors:  Sandra Juul; Ursula Felderhoff-Mueser
Journal:  Semin Fetal Neonatal Med       Date:  2007-02-23       Impact factor: 3.926

Review 4.  Neuroprotective therapies in the NICU in term infants: present and future.

Authors:  Eleanor J Molloy; Mohamed El-Dib; Sandra E Juul; Manon Benders; Fernando Gonzalez; Cynthia Bearer; Yvonne W Wu; Nicola J Robertson; Tim Hurley; Aoife Branagan; C Michael Cotten; Sidhartha Tan; Abbot Laptook; Topun Austin; Khorshid Mohammad; Elizabeth Rogers; Karen Luyt; Sonia Bonifacio; Janet S Soul; Alistair J Gunn
Journal:  Pediatr Res       Date:  2022-10-04       Impact factor: 3.953

5.  Intersecting guidelines: administering erythropoiesis-stimulating agents to chronic kidney disease patients with cancer.

Authors:  Charles L Bennett; Pamela S Becker; Eric H Kraut; Athena T Samaras; Dennis P West
Journal:  Semin Dial       Date:  2008-12-05       Impact factor: 3.455

6.  Erythropoietin as a neuroprotectant for neonatal brain injury: animal models.

Authors:  Christopher M Traudt; Sandra E Juul
Journal:  Methods Mol Biol       Date:  2013

7.  Erythropoietin for neuroprotection in neonatal encephalopathy: safety and pharmacokinetics.

Authors:  Yvonne W Wu; Larry A Bauer; Roberta A Ballard; Donna M Ferriero; David V Glidden; Dennis E Mayock; Taeun Chang; David J Durand; Dongli Song; Sonia L Bonifacio; Fernando F Gonzalez; Hannah C Glass; Sandra E Juul
Journal:  Pediatrics       Date:  2012-09-24       Impact factor: 7.124

8.  High plasma erythropoietin levels are associated with prolonged coma duration and increased mortality in children with cerebral malaria.

Authors:  Estela Shabani; Robert O Opoka; Richard Idro; Robert Schmidt; Gregory S Park; Paul Bangirana; Gregory M Vercellotti; James S Hodges; John A Widness; Chandy C John
Journal:  Clin Infect Dis       Date:  2014-09-16       Impact factor: 9.079

9.  Erythropoietin and its receptors in the brainstem of adults with fatal falciparum malaria.

Authors:  Isabelle M Medana; Nicholas P J Day; Tran Tinh Hien; Nicholas J White; Gareth D H Turner
Journal:  Malar J       Date:  2009-11-22       Impact factor: 2.979

10.  Erythropoietin improves motor and cognitive deficit, axonal pathology, and neuroinflammation in a combined model of diffuse traumatic brain injury and hypoxia, in association with upregulation of the erythropoietin receptor.

Authors:  Sarah C Hellewell; Edwin B Yan; Dasuni S Alwis; Nicole Bye; M Cristina Morganti-Kossmann
Journal:  J Neuroinflammation       Date:  2013-12-18       Impact factor: 8.322

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.